— Know what they know.
Not Investment Advice

IIN NASDAQ

IntriCon Corporation
1W: +0.9% 1M: +0.8% 3M: +44.1% 1Y: +1.1% 3Y: -2.8% 5Y: +218.9%
$24.23
Last traded 2022-05-24 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies

Balance Sheet Trends

Total Assets
$122M +1.0% ▲
5Y CAGR: +22.9%
Total Liabilities
$29M -4.6% ▼
5Y CAGR: +3.0%
Shareholders Equity
$94M +2.7% ▲
5Y CAGR: +38.2%
Cash & Investments
$25M -12.0% ▼
5Y CAGR: +106.4%
Total Debt
$5M -24.1% ▼
5Y CAGR: -14.7%
Net Debt
-$342K +79.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2018FY2019FY2020FY2021
— Assets —
Cash$373K$8M$9M$9M$6M
Short-Term Investments$0$38M$23M$20M$19M
Cash & ST Investments$373K$46M$33M$28M$25M
Net Receivables$9M$17M$19M$19M$20M
Inventory$15M$19M$16M$20M$24M
Other Current Assets$2M$2M$2M$2M$5M
Total Current Assets$27M$85M$70M$69M$74M
Property, Plant & Equip.$7M$12M$18M$21M$19M
Goodwill & Intangibles$14M$13M$10M$24M$23M
Long-Term Investments$2M$2M$10M$6M$5M
Other Non-Current Assets$4M$3M$6M$990K$1M
Total Non-Current Assets$26M$31M$43M$52M$48M
Total Assets$53M$115M$114M$121M$122M
— Liabilities —
Accounts Payable$10M$13M$10M$9M$9M
Short-Term Debt$2M$0$2M$2M$2M
Deferred Revenue$1M$786K$327K$184K$0
Other Current Liabilities$5M$8M$5M$8M$9M
Total Current Liabilities$19M$22M$17M$19M$20M
Long-Term Debt$9M$0$0$5M$3M
Other Non-Current Liab.$4M$2M$6M$6M$4M
Total Non-Current Liabilities$14M$2M$6M$11M$8M
Total Liabilities$33M$23M$23M$30M$29M
— Equity —
Common Stock$7M$9M$9M$9M$9M
Retained Earnings-$7M-$509K-$4M-$7M-$7M
Accumulated OCI-$733K-$927K-$520K-$679K-$393K
Total Stockholders Equity$21M$92M$91M$91M$94M
Total Liabilities & Equity$53M$116M$114M$121M$122M
— Key Metrics —
Total Debt$11M$0$5M$7M$5M
Net Debt$11M-$8M-$4M-$2M-$342K
Total Investments$2M$40M$33M$25M$24M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms